Hiroshi Akasaka

Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial

Jun Imagawa, Hideo Tanaka, Masaya Okada et al. · The Lancet Haematology · 2015 · 300 citations

Medicine, Hematology, Oncology +4

Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker

Masato Furuhashi, Norihito Moniwa, Teruaki Mita et al. · American Journal of Hypertension · 2014 · 272 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Estimated Daily Intake and Seasonal Food Sources of Quercetin in Japan

Haruno Nishimuro, Hirofumi Ohnishi, Midori Sato et al. · Nutrients · 2015 · 173 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +12

Dietary sodium-to-potassium ratio as a risk factor for stroke, cardiovascular disease and all-cause mortality in Japan: the NIPPON DATA80 cohort study

Akira Okayama, Nagako Okuda, Katsuyuki Miura et al. · BMJ Open · 2016 · 166 citations · Full text

Public Health, Nutrition, Nutritional Sciences +16

Circulating Levels of Fatty Acid-Binding Protein Family and Metabolic Phenotype in the General Population

Shutaro Ishimura, Masato Furuhashi, Yuki Watanabe et al. · PLoS ONE · 2013 · 156 citations · Full text

Life Sciences, Biochemistry, Clinical Biochemistry +9